NEWS

Thank you to the numerous Milner affiliated companies who have been in contact to offer support  to the University and NHS at this time. Help tackle COVID-19 through research collaborations, by donating equipment or funding research The University of Cambridge is...

As part of the response to COVID-19 at the University of Cambridge, the Milner Therapeutics Institute will be closed for non-essential business from Friday March 20th until further notice. Events planned for March and April, including the Milner seminar series, have...

We are delighted that Dr Konstantinos Tzelepis has moved into the Milner Centre for Pathway Analysis as a new Academic in Residence. He brings significant expertise in the identification and characterisation of novel therapeutic targets using a wide range of applied...

For the past four years, the Milner Therapeutics Institute has been incubating in the Gurdon Institute – home to the research lab of our Director Tony Kouzarides. This provided essential support as the Milner team was growing and developing key strategic partnerships,...

This month, we celebrated the launch of the Milner Therapeutics Institute in the Jeffrey Cheah Biomedical Centre. Key academics and consortium members gathered in our brand new auditorium. Our Director, Tony Kouzarides, gave the vision of the Milner Therapeutics...

We are excited to be celebrating the launch of the AstraZeneca-Cancer Research UK Functional Genomics Centre today. Based in the Milner Therapeutics Institute, this collaborative team will be utilising CRISPR technologies to better understand cancer biology, creating...

A warm welcome to the team of Kathryn Lilley at the Cambridge Centre for Proteomics (CCP), who are moving into the Milner Therapeutics Institute this week! The group have just returned from the Human Proteome Organisation (HUPO) meeting in Australia, where Kathryn...

A key goal of the Milner Therapeutics Consortium is to enable collaborations between Cambridge academics and our Consortium companies using forward-thinking pre-competitive models. We can now announce that the first such project has been established with Ludovic...

The Milner Therapeutics Institute will form part of a University Enterprise Zone, created through a new government initiative announced today by Universities Minister Chris Skidmore. Research England, part of UK Research and Innovation, today announced 20 new...

We are delighted to welcome the group of Manav Pathania (Dept Oncology), who moved into the Milner Institute this month. The Pathania group have a central focus on developing new mouse models for children’s brain tumours, to better understand the diverse genetic basis...